chloroquine has been researched along with panobinostat in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA | 1 |
Chan, SSL; Chou, CJ; Dolloff, N; Halene, S; Himes, RA; Inks, ES; Jiang, Y; Li, X; Luo, X; Peterson, YK; Xu, T; Yin, G | 1 |
Atadja, P; Balusu, R; Bhalla, KN; Chauhan, L; Fiskus, W; Ha, K; Hembruff, SL; Mudunuru, U; Rao, R; Smith, JE; Venkannagari, S | 1 |
Goodson, H; Helquist, P; Huegel, KL; Hulett, TW; Vaughan, KT; Wehrmann, ZT; Wiest, O | 1 |
González-Sarmiento, R; Herrero, AB; Ovejero-Sánchez, M | 1 |
González-Sarmiento, R; Herrero, AB; Ovejero-Sánchez, M; Pérez-Losada, J; Rubio-Heras, J; San-Segundo, L; Vicente de la Peña, MDC | 1 |
6 other study(ies) available for chloroquine and panobinostat
Article | Year |
---|---|
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins | 2018 |
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Leukemia, Myeloid, Acute; Male; Mice; Panobinostat; Tumor Suppressor Protein p53 | 2020 |
Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Chloroquine; Drug Synergism; Female; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Indoles; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Confocal; Panobinostat; Xenograft Model Antitumor Assays | 2012 |
Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.
Topics: Azacitidine; beta-Cyclodextrins; Cells, Cultured; Child; Child, Preschool; Chloroquine; Chlorpromazine; Cholesterol; Decitabine; Dose-Response Relationship, Drug; Drug Synergism; Female; Fibroblasts; Humans; Hydroxamic Acids; Indoles; Intracellular Space; Male; Microscopy, Fluorescence; Mutation; Niemann-Pick Disease, Type C; Panobinostat; Sirolimus; Vorinostat | 2012 |
Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chloroquine; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Drug Synergism; Female; Humans; Ovarian Neoplasms; Panobinostat; Reactive Oxygen Species; Recombinational DNA Repair | 2021 |
Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity.
Topics: Carcinoma, Ovarian Epithelial; Chloroquine; DNA Breaks, Double-Stranded; DNA Damage; DNA End-Joining Repair; DNA Repair; Female; Humans; Ovarian Neoplasms; Panobinostat; Reactive Oxygen Species | 2022 |